US 12213996
Methods of treating optic nerve diseases using neural progenitor cell growth factors
granted A61KA61K35/30A61K38/18
Quick answer
US patent 12213996 (Methods of treating optic nerve diseases using neural progenitor cell growth factors) held by REGENERATIVE RESEARCH FOUNDATION expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERATIVE RESEARCH FOUNDATION
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K35/30, A61K38/18, A61K38/1825, A61K38/1841